Question 32: Did the recipient receive concomitant therapy?

Concomitant therapy is given to enhance the function of the cellular therapy. In cases where a recipient has both HCT and cell therapy, this question applies to the cell therapy infusion, not the HCT. If the recipient had a prior HCT and the therapy was already captured on the HCT form as being HCT prep regimen, it is not reported again. See question 34 for a list of drugs that can be given as concomitant therapy.

Question 33: Specify start date:

Report the start date of the drug selected in question 342. Concomitant therapy can be given simultaneously with the cellular therapy infusion or up to 24 hours after infusion (post cell therapy).

Question 34-35: Specify drugs:

Select the drug(s) given as concomitant therapy. If the drug given is not in the list, check Other and specify the drug in question 35.

Section Updates:

Question Number Date of Change Add/Remove/Modify Description Reasoning (If applicable)
. . . . .
Last modified: Sep 23, 2022

Need more help with this?
Don’t hesitate to contact us here.

Was this helpful?

Yes No
You indicated this topic was not helpful to you ...
Could you please leave a comment telling us why? Thank you!
Thanks for your feedback.